Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Belgium Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20121
20131
20141
20152
20165
20175
20194
20201
20214
20225
20236
20243
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting11
Recruiting11
Terminated5
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Hoffmann-La Roche3
Pfizer3
Amgen2
AstraZeneca2
Bristol-Myers Squibb2
EMD Serono Research & Development Institute, Inc.2
AbbVie1
AmMax Bio, Inc.1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung45
Colorectal Neoplasms10
Melanoma8
Triple Negative Breast Neoplasms8
Lung Neoplasms7
Neoplasm Metastasis7
Ovarian Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Neoplasms5
Stomach Neoplasms5

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.